Astrana Health [ASTH] vs Select Medical [SEM] Detailed Stock Comparison
Astrana Health
NASDAQ
Loading...
Select Medical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Astrana Health wins in 6 metrics, Select Medical wins in 13 metrics, with 0 ties. Select Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astrana Health | Select Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 56.49 | 23.21 | Select Medical |
| Price-to-Book Ratio | 1.92 | 1.07 | Select Medical |
| Debt-to-Equity Ratio | 83.20 | 136.22 | Astrana Health |
| PEG Ratio | -1.08 | 6.37 | Astrana Health |
| EV/EBITDA | 13.84 | 12.71 | Select Medical |
| Profit Margin (TTM) | 1.04% | 3.33% | Select Medical |
| Operating Margin (TTM) | 3.11% | 8.33% | Select Medical |
| EBITDA Margin (TTM) | 3.11% | 8.33% | Select Medical |
| Return on Equity | 5.44% | 7.72% | Select Medical |
| Return on Assets (TTM) | 3.25% | 2.42% | Astrana Health |
| Free Cash Flow (TTM) | $44.17M | $295.69M | Select Medical |
| Dividend Yield | N/A | 65.77% | N/A |
| 1-Year Return | -37.72% | -32.24% | Select Medical |
| Price-to-Sales Ratio (TTM) | 0.57 | 0.35 | Select Medical |
| Enterprise Value | $1.37B | $4.91B | Select Medical |
| EV/Revenue Ratio | 0.57 | 0.94 | Astrana Health |
| Gross Profit Margin (TTM) | 11.91% | 13.34% | Select Medical |
| Revenue per Share (TTM) | $50 | $42 | Astrana Health |
| Earnings per Share (Diluted) | $0.53 | $0.62 | Select Medical |
| Beta (Stock Volatility) | 0.86 | 1.20 | Astrana Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Astrana Health vs Select Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astrana Health | 2.37% | 1.46% | 30.08% | 18.98% | -16.00% | -6.93% |
| Select Medical | 3.31% | 3.10% | -10.48% | -11.93% | -26.53% | -30.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astrana Health | -37.72% | -30.63% | 64.85% | 252.59% | 487.65% | 487.65% |
| Select Medical | -32.24% | -9.03% | 18.31% | 85.57% | 227.20% | 138.79% |
Performance & Financial Health Analysis: Astrana Health vs Select Medical
| Metric | ASTH | SEM |
|---|---|---|
| Market Information | ||
| Market Cap | $1.38B | $1.85B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 632,930 | 1,083,480 |
| 90 Day Avg. Volume | 438,513 | 1,361,833 |
| Last Close | $30.68 | $13.42 |
| 52 Week Range | $21.20 - $63.20 | $11.65 - $22.08 |
| % from 52W High | -51.46% | -39.22% |
| All-Time High | $133.23 (Nov 15, 2021) | $23.49 (Jun 21, 2021) |
| % from All-Time High | -76.97% | -42.87% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.35% | 0.02% |
| Quarterly Earnings Growth | -0.51% | -0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.03% |
| Operating Margin (TTM) | 0.03% | 0.08% |
| Return on Equity (TTM) | 0.05% | 0.08% |
| Debt to Equity (MRQ) | 83.20 | 136.22 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.58 | $13.40 |
| Cash per Share (MRQ) | $6.85 | $0.41 |
| Operating Cash Flow (TTM) | $130.56M | $581.10M |
| Levered Free Cash Flow (TTM) | $97.63M | $218.65M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 65.77% |
| Last 12-Month Dividend | N/A | $9.82 |
Valuation & Enterprise Metrics Analysis: Astrana Health vs Select Medical
| Metric | ASTH | SEM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 56.49 | 23.21 |
| Forward P/E | 19.57 | 6.37 |
| PEG Ratio | -1.08 | 6.37 |
| Price to Sales (TTM) | 0.57 | 0.35 |
| Price to Book (MRQ) | 1.92 | 1.07 |
| Market Capitalization | ||
| Market Capitalization | $1.38B | $1.85B |
| Enterprise Value | $1.37B | $4.91B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.57 | 0.94 |
| Enterprise to EBITDA | 13.84 | 12.71 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 1.20 |
| Book Value per Share (MRQ) | $15.58 | $13.40 |
Financial Statements Comparison: Astrana Health vs Select Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASTH | SEM |
|---|---|---|
| Revenue/Sales | $620.39M | $1.35B |
| Cost of Goods Sold | $549.06M | $1.17B |
| Gross Profit | $71.33M | $180.56M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $20.58M | $112.75M |
| EBITDA | $23.81M | $160.07M |
| Pre-Tax Income | $9.60M | $96.19M |
| Income Tax | $3.38M | $21.45M |
| Net Income (Profit) | $6.22M | $74.73M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASTH | SEM |
|---|---|---|
| Cash & Equivalents | $258.52M | $59.69M |
| Total Current Assets | $613.27M | $1.02B |
| Total Current Liabilities | $361.27M | $977.65M |
| Long-Term Debt | $433.40M | $2.48B |
| Total Shareholders Equity | $517.71M | $2.00B |
| Retained Earnings | $292.88M | $770.15M |
| Property, Plant & Equipment | $47.55M | $908.10M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASTH | SEM |
|---|---|---|
| Operating Cash Flow | $12.67M | $129.35M |
| Capital Expenditures | $-3.07M | $-63.43M |
| Free Cash Flow | $13.56M | $62.00M |
| Debt Repayment | $-428.38M | $-1.82B |
| Common Stock Repurchase | $-1.32M | $-19.98M |
Short Interest & Institutional Ownership Analysis
| Metric | ASTH | SEM |
|---|---|---|
| Shares Short | 1.61M | 3.83M |
| Short Ratio | 5.33 | 3.80 |
| Short % of Float | 0.06% | 0.07% |
| Average Daily Volume (10 Day) | 632,930 | 1,083,480 |
| Average Daily Volume (90 Day) | 438,513 | 1,361,833 |
| Shares Outstanding | 47.93M | 128.96M |
| Float Shares | 37.55M | 109.67M |
| % Held by Insiders | 0.22% | 0.14% |
| % Held by Institutions | 0.53% | 0.85% |
Dividend Analysis & Yield Comparison: Astrana Health vs Select Medical
| Metric | ASTH | SEM |
|---|---|---|
| Last 12-Month Dividend | N/A | $9.82 |
| Last 12-Month Dividend Yield | N/A | 65.77% |
| 3-Year Avg Annual Dividend | N/A | $3.44 |
| 3-Year Avg Dividend Yield | N/A | 4.54% |
| 3-Year Total Dividends | N/A | $10.31 |
| Ex-Dividend Date | N/A | Mar 03, 2025 |